Magnitude of change in BMD and bone turnover markers after cessation of risedronate treatment: Biological effect or statistical phenomenon?

被引：0
|
作者：
Kendler, D
Watts, NB
Zhou, X
Harris, ST
Grauer, A
机构：
[1] St Vincents Hosp, Vancouver, BC, Canada
[2] Univ Cincinnati, Cincinnati, OH 45221 USA
[3] P&G Pharmaceut, Mason, OH USA
[4] UCSF, San Francisco, CA USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2005年 / 20卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S402 / S402
页数：1
相关论文
共 50 条
  • [1] EFFECT OF RISEDRONATE TREATMENT DISCONTINUATION ON BONE TURNOVER AND BMD
    Watts, N. B.
    Olszynski, W. P.
    McKeever, C. D.
    Grauer, A.
    Chines, A.
    McClung, M. R.
    CALCIFIED TISSUE INTERNATIONAL, 2004, 74 : S79 - S79
  • [2] Effect of risedronate treatment discontinuation on bone turnover and BMD
    Watts, NB
    Olszynski, WP
    McKeever, CD
    Grauer, A
    Chines, A
    McClung, M
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S60 - S60
  • [3] Treatment discontinuation effects on bone turnover and BMD with risedronate
    Watts, N
    Olszynski, WP
    McKeever, CD
    Grauer, A
    Chines, A
    BONE, 2004, 34 : S99 - S99
  • [4] Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis
    Delmas, Pierre D.
    Vrijens, Bernard
    Eastell, Richard
    Roux, Christian
    Pols, Huibert A. P.
    Ringe, Johann D.
    Grauer, Andreas
    Cahall, David
    Watts, Nelson B.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (04): : 1296 - 1304
  • [5] Effect of Stopping Risedronate after Long-Term Treatment on Bone Turnover
    Eastell, Richard
    Hannon, Rosemary A.
    Wenderoth, Dietrich
    Rodriguez-Moreno, Jesus
    Sawicki, Andrzej
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (11): : 3367 - 3373
  • [6] Effect of early risedronate treatment on bone mineral density and bone turnover markers after liver transplantation: a prospective single-center study
    Guadalix, Sonsoles
    Martinez-Diaz-Guerra, Guillermo
    Lora, David
    Vargas, Carmela
    Gomez-Juaristi, Miren
    Cobaleda, Belen
    Moreno Gonzalez, Enrique
    Hawkins, Federico
    TRANSPLANT INTERNATIONAL, 2011, 24 (07) : 657 - 665
  • [7] Changes in bone turnover markers and BMD in women with osteoporosis after PTH 1-84 treatment
    Pastore, R.
    Mentuccia, D.
    Borboni, P.
    Frajese, V.
    BONE, 2009, 44 (02) : S440 - S441
  • [8] BMD AND BONE TURNOVER MARKERS ALTERATIONS IN WOMEN WITH ENDOMETRIOSIS DURING MENSTRUAL CESSATION DUE TO GNRH THERAPY AND AFTER MENSTRUAL RESTORATION
    Anastasilakis, A. D.
    Papachatzopoulos, S.
    Yavropoulou, M. P.
    Gkiomisi, A.
    Nikolakopoulos, P.
    Polyzos, S. A.
    Ballaouri, I.
    Aliazis, K.
    Barbounis, T.
    Papatheodorou, A.
    Fermanoglou, S.
    Makras, P.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S227 - S227
  • [9] Alendronate produces greater gains in BMD and greater reduction in markers of bone turnover than risedronate with similar tolerability.
    Rosen, C
    Hochberg, M
    Bonnick, S
    McClung, M
    Miller, P
    Broy, S
    Kagan, R
    Chen, E
    Petruschke, RA
    de Papp, AE
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S94 - S95
  • [10] 4 years continuous treatment with risedronate and its effect on bone turnover markers and quality of life of postmenopausal womwen
    不详
    CALCIFIED TISSUE INTERNATIONAL, 2006, 78 : S126 - S126
12345